A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

BACKGROUND: This phase I/II study examined the safety and efficacy of Sepantronium Bromide (S), a small-molecule selective survivin suppressant, administered in combination with carboplatin (C) and paclitaxel (P). PATIENTS AND METHODS: Forty-one patients were treated on study. Twenty-two patients re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kelly, R. J., Thomas, A., Rajan, A., Chun, G., Lopez-Chavez, A., Szabo, E., Spencer, S., Carter, C. A., Guha, U., Khozin, S., Poondru, S., Van Sant, C., Keating, A., Steinberg, S. M., Figg, W., Giaccone, G.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2013
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3784336/
https://ncbi.nlm.nih.gov/pubmed/23857959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt249
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker